AKAP signalling in chemotherapy-induced heart disease.

8 July 2016 (17:20 - 17:40)

Organised by:

About the speaker

Associate Professor Dario Diviani

Lausanne (Switzerland)

5 More presentations in this session

Presentation thumbnail

Sexual dimorphism of anthracycline cardiotoxicity

Doctor M. Moulin (Chatenay-Malabry, FR)

Presentation thumbnail

Targeting PI3Kgamma in cancer therapy: how to kill two birds with one stone.

Associate Professor A. Ghigo (Turin, IT)

Presentation thumbnail

Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy.

Assistant Professor S. Bollini (Genoa, IT)

Presentation thumbnail

Hyperlipidaemia reduces mortality in breast, prostate, lung and bowel cancer

Doctor P. Carter (Cambridge, GB)

Abstract Slides

Presentation thumbnail

DNA-repair in cardiomyocytes is critical for maintaining cardiac function

Miss M. De Boer (Rotterdam, NL)

Access the full session

Session thumbnail

Mechanisms of cancer-related cardiomyopathy

The Event

Frontiers in CardioVascular Biology 2016

8 July 2016 17:20 CET

You may be interested in

Congress Presentation

New target for chemotherapy-induced cardiac dysfunction

20 June 2025

Congress Session

Cardio-oncology: when therapy leads to failure

17 May 2025

Congress Presentation

New therapeutic strategy targeting regulation of the SERCA2 complex protects from myocardial ischemia-reperfusion injury

28 August 2023

Congress Presentation

Epigenetic repression by SAHA leads to cardio-protection in anthracycline-induced long-term cardiotoxicity

20 June 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources